Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H28O6 |
Molecular Weight | 376.4434 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(CCC(O)CC(O)CCC2=CC(OC)=C(O)C=C2)=CC=C1O
InChI
InChIKey=OELMAFBLFOKZJD-UHFFFAOYSA-N
InChI=1S/C21H28O6/c1-26-20-11-14(5-9-18(20)24)3-7-16(22)13-17(23)8-4-15-6-10-19(25)21(12-15)27-2/h5-6,9-12,16-17,22-25H,3-4,7-8,13H2,1-2H3
Molecular Formula | C21H28O6 |
Molecular Weight | 376.4434 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0042348 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25502175 |
|||
Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18427962 |
12.3 µM [IC50] | ||
Target ID: CHEMBL5281 Sources: https://www.ncbi.nlm.nih.gov/pubmed/30423402 |
PubMed
Title | Date | PubMed |
---|---|---|
Electron Paramagnetic Resonance Study of the Free Radical Scavenging Capacity of Curcumin and Its Demethoxy and Hydrogenated Derivatives. | 2015 |
|
Curcumin and its major metabolites inhibit the inflammatory response induced by lipopolysaccharide: translocation of nuclear factor-κB as potential target. | 2015 Apr |
|
Curcumin's Metabolites, Tetrahydrocurcumin and Octahydrocurcumin, Possess Superior Anti-inflammatory Effects in vivo Through Suppression of TAK1-NF-κB Pathway. | 2018 |
|
Octahydrocurcumin, a final hydrogenated metabolite of curcumin, possesses superior anti-tumor activity through induction of cellular apoptosis. | 2018 Apr 25 |
|
Development of Validated Methods and Quantification of Curcuminoids and Curcumin Metabolites and Their Pharmacokinetic Study of Oral Administration of Complete Natural Turmeric Formulation (Cureit™) in Human Plasma via UPLC/ESI-Q-TOF-MS Spectrometry. | 2018 Sep 20 |
|
Tetrahydrocurcumin and octahydrocurcumin, the primary and final hydrogenated metabolites of curcumin, possess superior hepatic-protective effect against acetaminophen-induced liver injury: Role of CYP2E1 and Keap1-Nrf2 pathway. | 2019 Jan |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:23:57 GMT 2023
by
admin
on
Sat Dec 16 11:23:57 GMT 2023
|
Record UNII |
YS2A8X6SX2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
36062-07-4
Created by
admin on Sat Dec 16 11:23:57 GMT 2023 , Edited by admin on Sat Dec 16 11:23:57 GMT 2023
|
PRIMARY | |||
|
DTXSID40873750
Created by
admin on Sat Dec 16 11:23:57 GMT 2023 , Edited by admin on Sat Dec 16 11:23:57 GMT 2023
|
PRIMARY | |||
|
YS2A8X6SX2
Created by
admin on Sat Dec 16 11:23:57 GMT 2023 , Edited by admin on Sat Dec 16 11:23:57 GMT 2023
|
PRIMARY | |||
|
11068834
Created by
admin on Sat Dec 16 11:23:57 GMT 2023 , Edited by admin on Sat Dec 16 11:23:57 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |